WS12.1 An exploratory study to determine the impact of lumacaftor/ivacaftor (LUM/IVA) on disease progression in children 2 through 5 years of age with cystic fibrosis homozygous for F508del-CFTR (F/F)

Saved in:
Bibliographic Details
Published in:Journal of cystic fibrosis 2021, Vol.20, p.S22-S23
Main Authors: Stahl, M., Roehmel, J., Eichinger, M., Doellinger, F., Naehrlich, L., Kopp, M.V., Dittrich, A.-M., Lee, C., Sommerburg, O., Tian, S., Xu, T., Wu, P., Joshi, A., Duncan, M., Wielpütz, M.O., Mall, M.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1569-1993
DOI:10.1016/S1569-1993(21)00981-4